A Growing Global Immune Cancer Medicine Market
Gulf Immune Cancer Medicines Market
The current market for precision immune medicines is expected to grow to over USD 15B by 2040, representing a CAGR of over 10%.
Global Immune Cancer Medicines Market
As personalised, precision medicine demonstrates superior control and relief from disease across many disease areas, the precision immune cancer medicines market globally has surged, with a CAGR of 16.5% delivering a global market value of USD110B by just 2032.
Access to a Global Export Market
IO:GULFs planned pipeline of medicines will make The Gulf region a major exporter of next generation cancer medicines. The advanced features of TCR bispecifics open up global patient populations by taking advantage of key genetic similarities during medicines development.
Manufacturing, Technology and Academic Opportunities
The phenomenal growth in the precision immune cancer medicines market gives rise to a vast array of opportunities. Developing, growing and scaling key technology transfer and manufacturing partnerships in The Gulf region at a global scale whilst bolstering the strength of the regional economy with local joint academic and commercial partnerships and ventures, and integrating local graduate talent into this profitable industry and maximising the benefits to The Gulf from the ground up.